U.S. Markets closed

Bain Capital Life Sciences Investors, LLC Buys Replimune Group Inc

- By insider

Investment company Bain Capital Life Sciences Investors, LLC buys Replimune Group Inc during the 3-months ended 2018-09-30, according to the most recent filings of the investment company, Bain Capital Life Sciences Investors, LLC. As of 2018-09-30, Bain Capital Life Sciences Investors, LLC owns 6 stocks with a total value of $441 million. These are the details of the buys and sells.

  • New Purchases: REPL,


For the details of Bain Capital Life Sciences Investors, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Bain+Capital+Life+Sciences+Investors%2C+LLC

These are the top 5 holdings of Bain Capital Life Sciences Investors, LLC

  1. Dicerna Pharmaceuticals Inc (DRNA) - 8,930,237 shares, 30.93% of the total portfolio.
  2. Solid Biosciences Inc (SLDB) - 1,989,444 shares, 21.3% of the total portfolio.
  3. Aptinyx Inc (APTX) - 2,225,092 shares, 14.62% of the total portfolio.
  4. InflaRx NV (IFRX) - 1,764,888 shares, 13.75% of the total portfolio. Shares reduced by 0.07%
  5. Replimune Group Inc (REPL) - 2,838,968 shares, 10.37% of the total portfolio. New Position

New Purchase: Replimune Group Inc (REPL)

Bain Capital Life Sciences Investors, LLC initiated holding in Replimune Group Inc. The purchase prices were between $14.99 and $22.14, with an estimated average price of $17.56. The stock is now traded at around $13.70. The impact to a portfolio due to this purchase was 10.37%. The holding were 2,838,968 shares as of 2018-09-30.



Here is the complete portfolio of Bain Capital Life Sciences Investors, LLC. Also check out:


1. Bain Capital Life Sciences Investors, LLC's Undervalued Stocks

2. Bain Capital Life Sciences Investors, LLC's Top Growth Companies, and

3. Bain Capital Life Sciences Investors, LLC's High Yield stocks

4. Stocks that Bain Capital Life Sciences Investors, LLC keeps buyingThis article first appeared on GuruFocus.